Introduction
Gastric cancer remains a leading cause of cancer death worldwide. Gastric resection is the mainstay of curative treatment. However, gastrectomy is a major surgery and the cost of hospitalization, while maintaining a good clinical outcome (Table 1) . To design the clinical pathway, a team of upper gastrointestinal surgeons, a nurse clinician, a dietitian, a physiotherapist, a pain care nurse, and a nurse coordinator was assembled. The team discussed each aspect of patient care and potential intervention. The timing of care was also streamlined in order to make the delivery of care more effi cient. There were several components to the clinical pathway; these are described below.
Preoperative education and counseling
All patients, as well as their family members and caregivers, were given detailed counseling, including written information regarding the gastrectomy, by a trained upper gastrointestinal nurse, to help them understand and prepare themselves for the operation and the perioperative period. An estimated discharge plan was also explained to them. If there were any anticipated difficulties with regards to the discharge of the patient; for example, fi nancial issues and home care, the case may have been referred to a medical social worker.
Pain control
Preoperatively, all patients were counseled by a trained pain nurse regarding postoperative pain management, including the usage of epidural analgesia and patient controlled analgesia (PCA). Perioperatively, individual anesthetists decided on the type of analgesia to be used. Postoperatively, the hospital pain management team managed the pain control.
Physiotherapy
Prior to surgery, all patients were educated by a physiotherapist on breathing exercises and the use of incentive spirometries. Cigarette smoking was strongly discouraged. On the fi rst postoperative day, patients were started on a structural mobilization plan to encourage early ambulation.
Nutritional support
Prior to surgery, all patients were assessed by a dietician. Protein supplements were given if patients were able to tolerate these orally. Postoperatively, liquid and solid diets were restarted early: on day 3 after subtotal gastrectomy and on day 5 after total gastrectomy. Once patients were able to tolerate the diets, they were started on protein supplements.
Surgical care
All operations were performed and managed by the upper gastrointestinal (UGI) surgical team. Nasogastric tubes were removed on day 1 after total gastrectomy and on day 3 after subtotal gastrectomy. Drains were removed once the output was clear (following the introduction of oral fl uids). For the prophylaxis of deep vein thrombosis, all patients received subcutaneous low-molecular weight heparin and wore pressure stockings.
Attending surgeons would initiate the entry of the pathway once the decision for surgery was made; usually at the outpatient clinics and occasionally in the wards. A preprinted checklist including pre-and postoperative orders was used. These checklists covered the routine aspects of patient care such as preoperative tests and postoperative care.
In the pre-pathway group, all patients were managed in the conventional manner by individual surgeons.
Statistics
All statistical analyses were made using the χ 2 test, Student's t-test, and an analysis of variance (ANOVA) test (where relevant). Results were generated with SPSS (ver 13; Chicago, IL, USA). P values of less than 0.05 (P < 0.05) were considered to be signifi cant.
Results
One hundred and fi fteen patients were enrolled in this study; 54 were operated on before the implementation of the clinical pathway for radical gastrectomy for gastric cancer (pre-pathway group) and 61 patients were operated on after the implementation of the pathway in August 2002 (pathway group). The patients' demographic data and comorbidities are summarized in Table 2 . There were no statistically signifi cant differences between the two groups with regards to age, ethnic group, and comorbidities (except for respiratory comorbidity). A signifi cant proportion of patients in each group had comorbid illnesses.
About one-third of patients in each group received a total gastrectomy. The rest had a subtotal gas trectomy (Table 3 ). The pathological stages of the cancer were similar in the two groups. Curative or R0 resection was achieved in 88.5% and 94.4% of the pathway and the pre-pathway patients, respectively. The number of lymph nodes harvested was greater in the pathway group compared to the pre-pathway group (P < 0.05).
The postoperative outcomes in the two groups are summarized in Table 4 . There were three deaths in the whole series (2.6%). The reasons for the deaths included bronchopneumonia, acute myocardial infarctions, and anastomotic leakages. There was no mortality in the pathway patients. Total and postoperative length of stay (LOS) in the hospital were both signifi cantly shorter in the pathway patients. The mean postoperative LOS for the pathway patients was 9 days, as compared to 11 days in the pre-pathway group (P = 0.02). The difference in mean postoperative LOS was 2.12 days (95% confidence interval [CI], 0.32 to 3.92). The difference in mean total LOS was 2.75 days (95% CI, 0.39 to 5.11). The mean total hospitalization cost for the pathway patients was signifi cantly lower, at S$13 338, as compared to S$17 371 in the pre-pathway patients (P < 0.05), with the mean difference in cost being S$4033 (95% CI, 58 to 8,009). Within 30 days after discharge, there were 11 (18.0%) readmissions in the pathway group and 7 (13.0%) in the pre-pathway group; the difference was not statistically signifi cant (P = 0.455). The reasons for readmission are shown in Table 5 .
Discussion
Our study demonstrated that a structured clinical pathway reduced both the hospital stay and the cost for patients undergoing gastrectomy for cancer. It is the fi rst study in the literature to evaluate a multidisciplinary perioperative program for gastrectomy patients. We have also shown that radical gastrectomy is a safe procedure with acceptable mortality and morbidity risks, when performed in a specialized unit.
As the cost of healthcare escalates rapidly over the years, means to reduce the costs of treatment are highly sought after. Clinical pathways have been developed to standardize the care for patients with a particular medical condition, or after a procedure. Such pathways minimize the variations in management by different care providers. To construct a clinical pathway, inputs from various disciplines are collected and decisions are made based on evidence-based medicine. In the past decade, pathways with a multimodal optimization program have been implemented for many types of major surgery, such as colectomies, cardiac bypasses, and pulmonary resections, with favorable results. The key principles of these enhanced recovery programs are adequate analgesia, early ambulation, and early resumption of oral intake [5, 8] .
Radical gastrectomy is a major surgical procedure, with signifi cant risks of morbidity and mortality [1, 2, [9] [10] [11] . Advanced age, coexisting illnesses, and malnutrition are common among gastric cancer patients. These factors further increase the risk of surgery [4] . In addition, upper abdominal incision is associated with significant postoperative pain, resulting in subsequent pulmonary atelectasis [12] . Nutritional counseling and support is one of our key components in this pathway. Dietitians, clinicians, and nurse clinicians are all involved. Prior to surgery, patients receive a high-protein diet with supplements whenever possible, as early satiety and malnutrition are common after gastrectomy [13] . Upon discharge from surgery, detailed counseling and visual information on diet are given to patients and their families. Chest physiotherapy with incentive spirometry is practiced aggressively before and after the surgery to prevent pulmonary atelectasis. Pain management carried out by a specialized team plays an integral part in our pathway in minimizing postoperative pain and its associated complications. The nurse clinician then coordinates various components of the pathway. There are some limitations in this study. Patients in the study were not randomized. However, we compared all patients immediately before and after implementation of the pathway for the study. The two groups were also comparable in terms of demographics and pathological features. It is diffi cult to conduct a randomized study nowadays as the institution of a clinical pathway would also infl uence the care of patients not on the pathway. Another introduced bias is the standard of surgery. Prior to the pathway period, both general and upper gastrointestinal surgeons performed gastrectomies. With the introduction of the pathway, patients in this group had gastrectomies performed only by two sub-specialist upper gastrointestinal surgeons [14] . This change of practice in our unit may have affected the operative standards, as suggested by the increased extent of lymph node dissection (mostly D2) in the pathway group [15] . However, extended nodal dissection may increase the risk of postoperative complications, which would favor the results of the pre-pathway group. In spite of this, patients in the pathway group had a shorter hospital stay with lower cost than those in the pre-pathway group.
One of the potential drawbacks in the pathway group was the readmission after discharge from the hospital [3] . Most readmissions were due to minor problems, some of which could have been avoided. Currently, all patients are assessed 1 day post-discharge via a telephone interview by our nurse clinician. They are also reviewed at the outpatient clinics within a week. These measures help to identify any postoperative problems early and, thus, avoid unnecessary readmissions to the hospital.
In summary, a clinical pathway with a multidisciplinary program improves the outcome of patients undergoing gastrectomy for gastric cancer. This pathway reduces both the length of hospitalization and the costs involved for that particular surgery.
